Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucom
PURPOSE: To compare 24-hour reduction in intraocular pressure (IOP) by latanoprost 0.005%, travoprost 0.004%, and bimatoprost 0.03% in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH).
DESIGN: Randomized, double-masked, crossover study.
PARTICIPANTS: Twenty-four patients with POAG and 20 with OH.